Diabetic Retinopathy Candesartan Trials
NCT00252733
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
5238
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
candesartan cilexetil
Sponsor
AstraZeneca
Collaborators
[object Object]